Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bioventus Inc.

7.43
-0.2200-2.88%
Post-market: 7.430.00000.00%16:10 EDT
Volume:350.67K
Turnover:2.62M
Market Cap:491.55M
PE:-14.30
High:7.68
Open:7.63
Low:7.41
Close:7.65
Loading ...

Bioventus to Report First Quarter of Fiscal Year 2025 Financial Results on May 6, 2025

GlobeNewswire
·
Yesterday

Bioventus Inc. (NASDAQ:BVS) On The Verge Of Breaking Even

Simply Wall St.
·
22 Apr

4 Healthcare Stocks to Buy as the Sector Faces Government Heat

Zacks
·
17 Apr

Should Weakness in Bravura Solutions Limited's (ASX:BVS) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

Simply Wall St.
·
10 Apr

Here's Why Bioventus (BVS) Is a Great 'Buy the Bottom' Stock Now

Zacks
·
31 Mar

Centene & HMHB Hawaii Expand Partnership for Maternal Care

Zacks
·
28 Mar

Bitcoin Beyond HODLing: SatLayer CEO Luke Xie on BTC Restaking and the Future of Bitcoin

BE[IN]CRYPTO
·
28 Mar

Bravura Solutions Adjusts Option Exercise Prices Following Capital Return

TIPRANKS
·
26 Mar

Centene's Meridian Unit Secures a D-SNP Contract in Illinois

Zacks
·
19 Mar

Bioventus Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
17 Mar

Institutional investors in Bravura Solutions Limited (ASX:BVS) see AU$121m decrease in market cap last week, although long-term gains have benefitted them.

Simply Wall St.
·
14 Mar

Q4 2024 Bioventus Inc Earnings Call

Thomson Reuters StreetEvents
·
12 Mar

Bioventus Inc (BVS) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Debt ...

GuruFocus.com
·
12 Mar

Bioventus Faces Potential Stock Dilution Risk Amid Resale of 35 Million Shares

TIPRANKS
·
12 Mar

Bravura Solutions Director Increases Shareholding

TIPRANKS
·
12 Mar

BUZZ-U.S. STOCKS ON THE MOVE-Elevance, Backblaze, Disney

Reuters
·
12 Mar

BUZZ-Bioventus jumps after upbeat Q4 results

Reuters
·
11 Mar

Medical Device Firm Bioventus Stock Jumps On Upbeat 2025 Outlook, Cuts Debt By $48 Million

Benzinga
·
11 Mar

Bioventus Shares Rise After Improved 4Q

Dow Jones
·
11 Mar

Bioventus (BVS) Q4 Earnings and Revenues Surpass Estimates

Zacks
·
11 Mar